Glucotrack Appoints Dr. Usman Latif to Clinical Advisory Team for Integrated Glucose Monitoring Applications.
ByAinvest
Wednesday, Oct 29, 2025 4:12 pm ET1min read
GCTK--
Glucotrack has appointed Dr. Usman Latif, an expert in neuromodulation and Painful Diabetic Neuropathy, to its clinical advisory team. Latif will help accelerate Glucotrack's strategy for integrated glucose monitoring applications, building on the company's 2024 expansion into epidural monitoring. Latif's expertise in pain management and product design will be invaluable as Glucotrack advances integrated disease and device management solutions for PDN patients.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet